The value of intraoperative near-infrared fluorescence imaging based on enhanced permeability and retention of indocyanine green: Feasibility and false-positives in ovarian cancer

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Tummers, Quirijn R J G ^a   Hoogstins, Charlotte E S ^a   Peters, Alexander A W ^a   De Kroon, Cor D ^a   Trimbos, J Baptist M Z ^a   Van De Velde, Cornelis J H ^a   Frangioni, John V ^b,c   Vahrmeijer, Alexander L ^a   Gaarenstroom, Katja N ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Curadel   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; FLUORESCENT DYE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DIAGNOSTIC VALUE; DRUG PENETRATION; DRUG RETENTION; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; FLUORESCENCE IMAGING SYSTEM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MIDDLE AGED; NEAR INFRARED FLUORESCENCE IMAGING; OMENTUM; OVARY CANCER; PERITONEAL CAVITY; PERITONEUM METASTASIS; UTERINE TUBE CARCINOMA; CLINICAL TRIAL; INTRAOPERATIVE MONITORING; METABOLISM; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PATHOLOGY; PERMEABILITY; PROCEDURES;

ADULT; AGED; FEMALE; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEOPLASM METASTASIS; OPTICAL IMAGING; OVARIAN NEOPLASMS; PERMEABILITY;

EID: 84938329604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129766     Document Type: Article

References (32)

1. Oncoline. www.oncoline.nl/epitheliaal-ovariumcarcinoom. Accessed: 28 August 2014.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi: 10.1002/ijc.25516 PMID: 21351269
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. caac.20107 [pii];doi: 10.3322/caac.20107 PMID: 21296855
4. Trimbos B, Timmers P, Pecorelli S, Coens C, Ven K, van der Burg M, et al. (2010) Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst 102: 982-987. djq149 [pii];doi: 10.1093/jnci/djq149 PMID: 20445161
5. Fader AN, Rose PG (2007) Role of surgery in ovarian carcinoma. J Clin Oncol 25: 2873-2883. 25/20/2873 [pii];doi: 10.1200/JCO.2007.11.0932 PMID: 17617518
6. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-Analysis. J Clin Oncol 20: 1248-1259. PMID: 11870167
7. Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, et al. 1994 The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am J Obstet Gynecol 170: 974-979. S0002937894000906 [pii]. PMID: 8166218
8. Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42: 101-104. PMID: 1234624
9. Colombo N, Van GT, Parma G, Amant F, Gatta G, Sessa C, et al. (2006) Ovarian cancer. Crit Rev Oncol Hematol 60: 159-179. S1040-8428(06)00064-3 [pii];doi: 10.1016/j.critrevonc.2006.03.004 PMID: 17018256
10. Vergote I, De W, I, Tjalma W, Van GM, Decloedt J, van DP (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71: 431-436. S0090-8258(98)95213-1 [pii];doi: 10.1006/gyno.1998.5213 PMID: 9887245
11. Vergote I, Trimbos BJ (2003) Treatment of patients with early epithelial ovarian cancer. Curr Opin Oncol 15: 452-455. PMID: 14624228
12. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. nrclinonc.2013.123 [pii];doi: 10. 1038/nrclinonc.2013.123
13. Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7: 626-634. S1367593103001091 [pii]. PMID: 14580568
14. van Dam GM, Crane LM, Themelis G, Harlaar NJ, Pleijhuis RG, kelder W, et al. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-Alpha targeting: first in-human results. Nat Med Sep 18; 17(10):1315-9. doi: 10.1038/nm.2472 PMID: 21926976
15. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Lowik CW, et al. (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104: 323-332. doi: 10.1002/jso.21943 PMID: 21495033
16. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65: 271-284. S0168-3659(99)00248-5 [pii]. PMID: 10699287
17. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46: 6387-6392. PMID: 2946403
18. Alacam B, Yazici B, Intes X, Nioka S, Chance B (2008) Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods. Phys Med Biol 53: 837-859. S0031-9155 (08)62576-2 [pii];doi: 10.1088/0031-9155/53/4/002 PMID: 18263944
19. Hagen A, Grosenick D, Macdonald R, Rinneberg H, Burock S, Warnick P, et al. (2009) Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions. Opt Express 17: 17016-17033. 185849 [pii]. doi: 10.1364/OE.17.017016 PMID: 19770920
20. Kimura T, Muguruma N, Ito S, Okamura S, Imoto Y, Miyamoto H, et al. (2007) Infrared fluorescence endoscopy for the diagnosis of superficial gastric tumors. Gastrointest Endosc 66: 37-43. S0016-5107 (07)00022-3 [pii];doi: 10.1016/j.gie.2007.01.009 PMID: 17591472
21. Mataki N, Nagao S, Kawaguchi A, Matsuzaki K, Miyazaki J, Kitagawa Y, et al. (2003) Clinical usefulness of a new infrared videoendoscope system for diagnosis of early stage gastric cancer. Gastrointest Endosc 57: 336-342. doi: 10.1067/mge.2003.133;S0016510703501766 [pii]. PMID: 12612512
22. Ntziachristos V, Yodh AG, Schnall M, Chance B (2000) Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 97: 2767-2772. doi: 10. 1073/pnas.040570597;040570597 [pii]. PMID: 10706610
23. Poellinger A, Burock S, Grosenick D, Hagen A, Ludemann L, Diekmann F, et al. (2011) Breast cancer: early-And late-fluorescence near-infrared imaging with indocyanine green-A preliminary study. Radiology 258: 409-416. radiol.10100258 [pii];doi: 10.1148/radiol.10100258 PMID: 21177396
24. Kosaka N, Mitsunaga M, Longmire MR, Choyke PL, Kobayashi H (2011) Near infrared fluorescenceguided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer 129: 1671-1677. doi: 10.1002/ijc.26113 PMID: 21469142
25. Fang J, Nakamura H, Maeda H (2011) The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63: 136-151. S0169-409X(10)00090-6 [pii];doi: 10.1016/j.addr.2010.04.009 PMID: 20441782
26. Maeda H (2012) Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci 88: 53-71. JST.JSTAGE/pjab/88.53 [pii]. PMID: 22450535
27. Mieog JS, Troyan SL, Hutteman M, Donohue KJ, van der Vorst JR, Stockdale A, et al. (2011) Towards Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer. Ann Surg Oncol 18: 2483-2491. doi: 10.1245/s10434-011-1566-x PMID: 21360250
28. Maeda H, Fang J, Inutsuka T, Kitamoto Y (2003) Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 3: 319-328. S1567-5769(02)00271-0 [pii];doi: 10.1016/S1567-5769(02)00271-0 PMID: 12639809
29. Maeda H (2013) The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci 104: 779-789. doi: 10.1111/cas.12152 PMID: 23495730
30. van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, et al. (2013) Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer 119: 3411-3418. doi: 10.1002/cncr.28203 PMID: 23794086
31. van der Vorst JR, Schaafsma BE, Verbeek FP, Swijnenburg RJ, Tummers QR, Hutteman M, et al. (2013) Intraoperative near-infrared fluorescence imaging of parathyroid adenomas with use of lowdose methylene blue. Head Neck. doi: 10.1002/hed.23384
32. Tummers QR, Verbeek FP, Schaafsma BE, Boonstra MC, van der Vorst JR, Liefers GJ, et al. (2014) Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue. Eur J Surg Oncol 40: 850-858. S0748-7983(14)00303-5 [pii];doi: 10.1016/j.ejso.2014.02. 225 PMID: 24862545